<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mitochondrial regulation and functions</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mitochondrial regulation and functions</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mitochondrial regulation and functions</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Erin O'Ferrall, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeremy M Shefner, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sihoun Hahn, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer S Tirnauer, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 24, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Mitochondrial abnormalities may be seen in primary mitochondrial disorders (chronic, genetically determined disorders in which the primary problem is mitochondrial dysfunction) as well as acquired conditions with mitochondrial dysfunction (such as due to other medical conditions or medications). Primary mitochondrial disorders can be caused by pathogenic variants in genes in nuclear DNA or mitochondrial DNA (mtDNA).</p><p>This topic will give a brief overview of mitochondrial structure, regulation, genetics, and functions. </p><p>Mitochondrial disorders are discussed in separate topic reviews listed in the sections below. (See <a class="local">'Primary mitochondrial disorders'</a> below and <a class="local">'Disorders with altered mitochondrial function'</a> below and <a class="local">'Drug-induced mitochondrial disorders'</a> below.)</p><p class="headingAnchor" id="H646625876"><span class="h1">TYPES OF MITOCHONDRIAL DISORDERS</span></p><p class="headingAnchor" id="H2980718663"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Estimates from Northern England suggest that the prevalence of mitochondrial disorders due to pathogenic variants in nuclear DNA is 2.9 per 100,000 and due to pathogenic variants in mitochondrial DNA (mtDNA) is 20 per 100,000 persons [<a href="#rid1">1</a>]. Overall, this indicates a prevalence of 1 in 4300 for mitochondrial diseases caused by pathogenic variants in nuclear or mtDNA. </p><p>It was once believed that nuclear DNA disorders tended to present in childhood while mtDNA disorders (whether primary or secondary to nuclear DNA abnormalities) tended to present in late childhood or adulthood. However, it is now clear that both nuclear DNA and mtDNA disorders can present throughout life [<a href="#rid2">2</a>]. </p><p class="headingAnchor" id="H2412178233"><span class="h2">Primary mitochondrial disorders</span><span class="headingEndMark"> — </span>Primary mitochondrial diseases are genetically determined disorders in which mitochondrial dysfunction is responsible for the clinical disorder. They can be caused by pathogenic variants affecting germline nuclear DNA or mtDNA. (See <a class="local">'Mitochondrial genetics'</a> below.)</p><p>These encompass several types of clinical phenotypes based on which organ system(s) are affected:</p><p class="bulletIndent1"><span class="glyph">●</span>Myopathies </p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic diseases (including encephalomyopathies, neuropathies, and ataxias) </p><p class="bulletIndent1"><span class="glyph">●</span>Multisystemic diseases </p><p></p><p>The high mutation rate in mtDNA is discussed below. (See <a class="local">'High mutation rate and variable phenotypic expression'</a> below.)</p><p>Details of evaluation and management are presented separately:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myopathies and encephalomyopathies</strong> – (See  <a class="medical medical_review" href="/d/html/5151.html" rel="external">"Mitochondrial myopathies: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5149.html" rel="external">"Mitochondrial disorders: Treatment"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuropathies</strong> – (See  <a class="medical medical_review" href="/d/html/6226.html" rel="external">"Neuropathies associated with hereditary disorders", section on 'Mitochondrial disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebellar ataxias</strong> – (See  <a class="medical medical_review" href="/d/html/6234.html" rel="external">"Overview of the hereditary ataxias", section on 'Mitochondrial ataxias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amyotrophic lateral sclerosis</strong> – (See  <a class="medical medical_review" href="/d/html/5156.html" rel="external">"Epidemiology and pathogenesis of amyotrophic lateral sclerosis", section on 'Pathology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pearson syndrome</strong> – (See  <a class="medical medical_review" href="/d/html/5151.html" rel="external">"Mitochondrial myopathies: Clinical features and diagnosis", section on 'Pearson syndrome'</a> and  <a class="medical medical_review" href="/d/html/7122.html" rel="external">"Causes and pathophysiology of the sideroblastic anemias", section on 'Pearson syndrome (large deletion of mitochondrial DNA)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mitochondrial disorders causing systemic disease </strong>– (See  <a class="medical medical_review" href="/d/html/2930.html" rel="external">"Inborn errors of metabolism: Classification", section on 'Mitochondrial disorders'</a>.)</p><p></p><p>Understanding of the phenotypic and genotypic diversity of mitochondrial disease has expanded enormously. This understanding has challenged the previously held view that mitochondrial diseases are limited to those affecting (directly or indirectly) the proteins of the respiratory chain. Primary mitochondrial diseases now include diseases affecting other mitochondrial functions including mitochondrial dynamics (fission &amp; fusion), apoptosis, mitochondrial membrane homeostasis, nonrespiratory pathways, and others  (<a class="graphic graphic_table graphicRef55067" href="/d/graphic/55067.html" rel="external">table 1</a>) [<a href="#rid3">3-7</a>]. </p><p class="headingAnchor" id="H1682474621"><span class="h2">Disorders with altered mitochondrial function</span><span class="headingEndMark"> — </span>Mitochondrial dysfunction is emerging as important in the pathogenesis of a variety of conditions including:</p><p class="bulletIndent1"><span class="glyph">●</span>Neurodegenerative diseases (Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis) </p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular disease</p><p class="bulletIndent1"><span class="glyph">●</span>Cancer</p><p class="bulletIndent1"><span class="glyph">●</span>Immunity </p><p class="bulletIndent1"><span class="glyph">●</span>Liver disease</p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic brain injury</p><p class="bulletIndent1"><span class="glyph">●</span>Stroke (ischemia and reperfusion)</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune disease (systemic lupus erythematosus [SLE], rheumatoid arthritis)</p><p class="bulletIndent1"><span class="glyph">●</span>Wound healing </p><p class="bulletIndent1"><span class="glyph">●</span>Aging </p><p></p><p>These conditions are not primary mitochondrial disorders, and they may have multiple mechanisms that include cellular functions independent of mitochondria or that impact mitochondria only indirectly. However, they illustrate how mitochondria play a role in a wide variety of human diseases. </p><p>For neurodegenerative disorders, the pathogenesis appears to involve oxidative stress, among other mechanisms, as discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4906.html" rel="external">"Epidemiology, pathogenesis, and genetics of Parkinson disease", section on 'Mitochondrial dysfunction'</a> and  <a class="medical medical_review" href="/d/html/5075.html" rel="external">"Prevention of dementia", section on 'Antioxidant vitamins'</a> and  <a class="medical medical_review" href="/d/html/6182.html" rel="external">"Huntington disease: Genetics and pathogenesis", section on 'Mutant huntingtin'</a>.)</p><p>Roles of mitochondria in immunity and aging are discussed below. (See <a class="local">'Inflammation and immunity'</a> below and <a class="local">'Role in aging'</a> below.)</p><p class="headingAnchor" id="H3421738601"><span class="h2">Drug-induced mitochondrial disorders</span><span class="headingEndMark"> — </span>Certain antiviral or antibacterial drugs target mitochondrial function.</p><p>Selected examples are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Antiviral reverse transcriptase inhibitors. (See  <a class="medical medical_review" href="/d/html/3765.html" rel="external">"Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Antibacterial therapies. (See  <a class="medical medical_review" href="/d/html/129184.html" rel="external">"Linezolid and tedizolid (oxazolidinones): An overview", section on 'Adverse effects'</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">STRUCTURE AND REGULATION</span></p><p class="headingAnchor" id="H2211290237"><span class="h2">Origin</span><span class="headingEndMark"> — </span>Mitochondria are intracellular organelles thought to be derived from aerobic bacteria that invaded the proto eukaryotic cell more than a billion years ago and lived in a symbiotic relationship with it, exchanging energy (in the form of adenosine triphosphate [ATP]) for residence inside the cell and use of cellular proteins [<a href="#rid8">8</a>]. However, this "endosymbiotic hypothesis" is not universally accepted and has been challenged [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H676696000"><span class="h2">Distribution</span><span class="headingEndMark"> — </span>Mitochondria are found in virtually every cell type in the human body, on average hundreds to thousands of mitochondria per cell [<a href="#rid10">10</a>]. The only cells lacking mitochondria are mature red blood cells (RBCs), which rely exclusively on anaerobic glycolysis for energy production. Mitochondria are extruded from RBCs, along with the cell nucleus, during the later stages of normoblast maturation [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/7128.html" rel="external">"Rare RBC enzyme disorders", section on 'Glycolysis pathway'</a> and  <a class="medical medical_review" href="/d/html/7161.html" rel="external">"Regulation of erythropoiesis", section on 'Precursors and mature cells'</a>.)</p><p>Mitochondria are reported to be especially abundant in cells with high metabolic requirements, including muscle, nerve, liver, and kidney [<a href="#rid9">9</a>].</p><p>Sperm contain approximately 50 to 75 mitochondria that generate energy to power sperm motility, but these are selectively destroyed shortly after fertilization [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/7474.html" rel="external">"Male reproductive physiology", section on 'Spermatogenesis'</a>.)</p><p class="headingAnchor" id="H1662188935"><span class="h2">Membrane and functional compartments</span><span class="headingEndMark"> — </span>Mitochondria have four main compartments bounded by phospholipid membranes  (<a class="graphic graphic_figure graphicRef67253" href="/d/graphic/67253.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outer membrane</strong> – Serves as a boundary between the mitochondria and the cytosol. It is permeable to certain ions and small molecules.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inner membrane</strong> – It is folded into multiple cristae, allowing for a large surface area. It is the site of the respiratory chain proteins. It is essential for the electrochemical gradient and the production of ATP, and it provides the scaffold for the respiratory chain on the inner mitochondrial membrane [<a href="#rid6">6,13</a>]. (See <a class="local">'Metabolism and ATP production'</a> below.)</p><p></p><p class="bulletIndent1">Cardiolipin is the major phospholipid of the internal mitochondrial membrane. Tafazzin is a phospholipid-lysophospholipid transacylase required for cardiolipin synthesis. Anticardiolipin antibodies are a type of autoantibody seen in antiphospholipid syndrome. (See  <a class="medical medical_review" href="/d/html/4667.html" rel="external">"Clinical manifestations of antiphospholipid syndrome", section on 'Antiphospholipid antibodies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intermembrane space</strong> – Has a composition similar to that of the cytosol. Multiple transmembrane transport systems regulate the exchange of calcium ions, sodium ions, and protons between the matrix and the cystosol [<a href="#rid14">14</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Matrix</strong> – This inner part of the mitochondrion is where the mitochondrial DNA (mtDNA) is located and where most of the metabolic reactions take place. (See <a class="local">'Mitochondrial DNA, RNA, and protein synthesis'</a> below.)</p><p></p><p>The mitochondrial membrane interacts with the endoplasmic reticulum through specialized lipid raft domains termed MAMs (mitochondria-associated endoplasmic reticulum membranes) [<a href="#rid15">15,16</a>]. MAMs have roles in lipid biosynthesis and transport, calcium signaling, energy metabolism, apoptosis, and mitochondrial dynamics.</p><p>Choline kinase-beta is an enzyme involved in the biosynthesis of phosphatidylcholine in the MAM. The serine active site-containing protein 1 (SERAC1) is a MAM protein involved in exchange of phospholipids between the endoplasmic reticulum and the mitochondria.</p><p class="headingAnchor" id="H2309966560"><span class="h2">Fusion and fission dynamics</span><span class="headingEndMark"> — </span>While mitochondria were initially presumed to exist as predominantly isolated organelles, this is no longer thought to be the case [<a href="#rid8">8</a>]. Instead, the mitochondria exist as a dynamic interconnected network (also called a syncytium or reticulum) that is constantly undergoing fusion and fission. </p><p>The dynamic nature of this ongoing remodeling process distributes the mitochondrial metabolic capacity and genomes throughout the cell and may have other purposes that are still poorly understood. </p><p>The processes of fusion and fission involve the dynamin-related proteins, which hydrolyze GTP to provide energy. These are encoded by nuclear genes. Fission requires dynamin-related protein 1 (Drp1) and dynamin 2. Endoplasmic reticulum tubules wrap around mitochondria and mark the sites of mitochondrial division. Fusion is performed by mitofusin 1/mitofusin 2 and OPA1. Mitochondrial dynamic abnormalities have been observed in various major neurodegenerative diseases [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H2369871948"><span class="h2">Relationship between mitochondrial division and the cell division cycle</span><span class="headingEndMark"> — </span>Unlike nuclear DNA, replication and segregation of mitochondrial DNA is not coupled to the cell division cycle and can occur at any time. This allows for postmitotic mitochondrial DNA replication in terminally differentiated cells such as neurons or muscle and in response to specific stimuli (exercise, increased metabolic demand). </p><p>There are two ways in which pathogenic variants in mitochondrial genes can exceed the symptomatic threshold in a previously unaffected tissue (see <a class="local">'Threshold effect'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Postmitotic mitochondrial DNA replication can result in expansion of a population of mitochondria carrying the pathogenic variant. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Random distribution of mitochondria within the cell cytoplasm can result in an abundance of mitochondria carrying the pathogenic variant in one of the daughter cells following mitosis, to the point that the level surpasses the threshold. </p><p></p><p>The clinical phenotype can then change in a previously unaffected tissue later in life. </p><p class="headingAnchor" id="H2760237168"><span class="h2">Mitochondrial DNA, RNA, and protein synthesis</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Circular genome</strong> –<strong> </strong>Mitochondrial DNA (mtDNA) consists of a single, 16,569 base pair double-stranded circular DNA molecule  (<a class="graphic graphic_figure graphicRef73757" href="/d/graphic/73757.html" rel="external">figure 2</a>) that encode 13 proteins, as well as genes for two transfer RNAs and 22 ribosomal RNAs, for a total of 37 mitochondrial genes in a structure called a nucleoid [<a href="#rid8">8,18-20</a>]. Of the estimated 1700 proteins required for mitochondrial function, only these 13 proteins, two ribosomal RNAs, and 22 transfer RNAs are encoded by mtDNA; the remainder are encoded by the nuclear genome. (See <a class="local">'Mitochondrial genetics'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nucleoids</strong> – Each nucleoid contains one or two mtDNA molecules complexed with regulatory proteins, and each mitochondria contains approximately three nucleoids (most only contain one) [<a href="#rid21">21</a>]. These nucleoids are located in the mitochondrial matrix. </p><p></p><p class="bulletIndent1">Rather than the typical structure of eukaryotic nuclear chromosomes (with a centromere, paired sister chromatids with long and short arms, and telomeres), mtDNA is more similar to a bacterial chromosome in being circular. mtDNA also lacks histones, which are present in nuclear chromosomes; histones allow condensation and compaction of DNA, protect certain regions of the DNA sequence, and regulate transcription. (See  <a class="medical medical_review" href="/d/html/14601.html" rel="external">"Principles of epigenetics", section on 'Histone modifications'</a>.)</p><p></p><p class="bulletIndent1">However, like nuclear chromosomes, the DNA is complexed with proteins required for replication, maintenance, and repair of the mtDNA [<a href="#rid8">8</a>]. The proteins are encoded by genes in the cell nucleus that are imported into mitochondria.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transcription</strong> – Mitochondria have their own machinery for DNA transcription and RNA translation. The polymerase used for mt DNA replication is DNA polymerase gamma (PolG, encoded by nuclear genes <em>POLG </em>[polymerase], <em>POLG2 </em>[accessory subunit], <em>TWNK </em>[DNA helicase] and <em>DNA2</em> [helicase/nuclease]). Pathogenic variants in these nuclear genes can cause mtDNA depletion, deletions, and/or site-specific mutations [<a href="#rid6">6</a>]. </p><p></p><p class="bulletIndent1">The substrates for replication include the four deoxynucleoside triphosphates (dNTPS: dATP, dGTP, dCTP, dTTP). Pathogenic variants affecting the enzymes controlling the balance of the four dNTPs have been implicated in human diseases. </p><p></p><p class="bulletIndent1">The 11 mtDNA genes are transcribed into 11 mRNAs, which are then translated by mitochondrial ribosomes (mitoribosomes) into 13 proteins of the respiratory chain, used to produce energy in the form of ATP (adenosine triphosphate) [<a href="#rid6">6</a>]. (See <a class="local">'Metabolism and ATP production'</a> below.)</p><p></p><p class="bulletIndent1">The genetic code of mitochondrial DNA differs slightly from the universal genetic code of nuclear DNA in that certain mitochondrial trinucleotides encode different amino acids or stop codons than those in the universal genetic code. (See  <a class="medical medical_review" href="/d/html/2900.html" rel="external">"Basic genetics concepts: DNA regulation and gene expression", section on 'Gene expression'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Translation machinery</strong> – Translation of these mRNAs into protein is a hugely complex process that occurs inside the mitochondria but relies on the import of an impressive number of nuclear-encoded proteins including [<a href="#rid22">22,23</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Components of the large and small subunits of the ribosome (comprised of 48 and 29 proteins, respectively)</p><p class="bulletIndent2"><span class="glyph">•</span>Translation initiation, elongation and release factors</p><p class="bulletIndent2"><span class="glyph">•</span>Ribosomal protein assembly factors</p><p class="bulletIndent2"><span class="glyph">•</span>mRNA polyadenylation factors</p><p class="bulletIndent2"><span class="glyph">•</span>Translational activators</p><p></p><p class="bulletIndent1">Two of the required ribosomal RNAs are encoded by mtDNA. In addition, the 22 mitochondria-encoded transfer RNAs used in translation are post-transcriptionally modified by proteins encoded by the nuclear genome that are also imported into the mitochondria.</p><p></p><p class="bulletIndent1">Abnormalities of mitochondrial protein synthesis cause a wide phenotypic spectrum of human disease and have so far been described due to mutations in the mitochondrial ribosomal RNAs, mitoribosomal proteins, or in mitoribosomal assembly factors [<a href="#rid22">22</a>]. </p><p></p><p class="headingAnchor" id="H3427678106"><span class="h1">CELLULAR FUNCTIONS</span><span class="headingEndMark"> — </span>Mitochondria are involved in aerobic metabolism, energy production in the form of ATP (adenosine triphosphate), and several other metabolic pathways discussed below.</p><p class="headingAnchor" id="H3744274842"><span class="h2">Metabolism and ATP production</span><span class="headingEndMark"> — </span>Mitochondria are the "powerhouses" of the cell. They are essential for aerobic metabolism and production of ATP, the main source of energy for all cellular processes. </p><p>The metabolic pathways are illustrated in the figure  (<a class="graphic graphic_figure graphicRef67253" href="/d/graphic/67253.html" rel="external">figure 1</a>). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Substrates for metabolism</strong> – The initial source of substrates for metabolism are free fatty acids and carbohydrates (in the form of pyruvate), which are imported into the mitochondria. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fatty acids cross the outer mitochondrial membrane through carnitine palmitoyltransferase 1 and then cross the inner mitochondrial membrane with the help of carnitine palmitoyltransferase 2. Free fatty acids are metabolized to acetyl-CoA through beta-oxidation in the mitochondrial matrix. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pyruvate is decarboxylated to acetyl-CoA by the pyruvate dehydrogenase enzyme complex. Acetyl-coA then enters the Krebs cycle (also known at the citric acid cycle or the tricarboxylic acid cycle), which also occurs in the mitochondrial matrix. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The Krebs cycle oxidizes acetyl-coA to carbon dioxide and water. This produces hydrogen ions, which reduce nicotinamide-adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD) to NADH and FADH<sub>2</sub>. Subsequently, NADH and FADH<sub>2 </sub>provide hydrogen ions for the respiratory chain. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron sulfur clusters</strong> – Iron-sulfur clusters are essential cofactors for respiratory chain complexes I, II, and III as well as aconitase (from the Krebs cycle)  (<a class="graphic graphic_figure graphicRef78699" href="/d/graphic/78699.html" rel="external">figure 3</a>) [<a href="#rid24">24</a>]. </p><p></p><p class="bulletIndent1">Iron-sulfur clusters are synthesized within the mitochondria, in a process requiring ATP, guanosine triphosphate (GTP), NADH, and iron.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory chain</strong> – The respiratory chain (also called the electron transport chain) is composed of five enzyme complexes located on the inner mitochondrial membrane  (<a class="graphic graphic_figure graphicRef82715" href="/d/graphic/82715.html" rel="external">figure 4</a>). The proteins in the respiratory chain are encoded by mitochondrial DNA (mtDNA) and nuclear DNA. In addition to providing protein subunits for the respiratory chain, nuclear DNA also provides the protein machinery necessary to translate, import, and assemble these nuclear-encoded proteins [<a href="#rid25">25</a>]. Pathogenic variants in these nuclear genes can also cause mitochondrial disease  (<a class="graphic graphic_table graphicRef55067" href="/d/graphic/55067.html" rel="external">table 1</a>). (See <a class="local">'Mitochondrial genetics'</a> below.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complex I (NADH dehydrogenase-ubiquinone oxidoreductase) </strong>– Contains approximately 46 subunits, seven of which are of mtDNA origin (ND1, ND2, ND3, ND4, ND4L, ND5 and ND6). Complex I receives electrons from NADH.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complex II (succinate dehydrogenase-ubiquinone oxidoreductase)</strong> – Contains four subunits, all of nuclear DNA origin. Complex II receives electrons from succinate. </p><p></p><p class="bulletIndent2">NADH and succinate are both products of the Krebs cycle. Their electrons are transferred horizontally from complex I and II to a mobile lipid carrier in the inner membrane, co-enzyme Q10, which in turn transfers them to complex III.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complex III (ubiquinone-cytochrome c oxidoreductase)</strong> – Contains 11 subunits. Only one, cytochrome b, is encoded by mtDNA. The electrons are transferred from complex III to complex IV by cytochrome c, another protein mobile carrier, in the intermembrane space.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complex IV (cytochrome c oxidase</strong>) – Contains 13 subunits, three of mtDNA origin (COXI, COXII, and COXIII). Complex IV uses oxygen as the final electron acceptor to produce water molecules.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complex V (ATP synthase)</strong> – Contains 16 subunits, two of mtDNA origin (ATP6 and ATP8).</p><p></p><p class="bulletIndent1">Using the energy released by the electron transfers, complexes I, III, and IV pump protons (H<sup>+</sup>) from the matrix to the intermembrane space, creating an electrochemical proton gradient across the inner membrane. ATP is then generated by complex V when protons flow back down their electrochemical gradient to the mitochondrial matrix.</p><p></p><p class="bulletIndent1">The respiratory chain can also generate reactive oxygen species (ROS) via interactions of electrons with molecular oxygen to form superoxide, a type of ROS [<a href="#rid26">26,27</a>]. Complex I and III, and to a lesser extent Complex II, are thought to be the major sites contributing to mitochondrial ROS generation. ROS have multiple effects, including direct damage of proteins, lipids and nucleic acids (through oxidation), and acting as second messengers for apoptosis pathways. (See <a class="local">'Apoptosis'</a> below.)</p><p></p><p class="headingAnchor" id="H2402860678"><span class="h2">Apoptosis</span><span class="headingEndMark"> — </span>Apoptosis describes a complex and highly regulated form of cell death distinct from necrosis. </p><p>Mitochondria can regulate apoptosis by at least two pathways [<a href="#rid28">28</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Apoptosis involving the BCL-2, BAX, and caspase apoptosis pathway. (See  <a class="medical medical_review" href="/d/html/5594.html" rel="external">"Apoptosis and autoimmune disease", section on 'Molecular mechanisms of apoptosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mitochondrial transition-driven necrosis [<a href="#rid28">28</a>].</p><p></p><p>Apoptotic signals such as DNA damage, calcium excess, oxidative stress, and endoplasmic reticulum stress can be transduced to the mitochondria, resulting in opening of the mitochondrial outer membrane and the release of proapoptotic factors [<a href="#rid26">26</a>]. Reactive oxygen species (ROS) produced by mitochondria can lead to oxidation of cardiolipin and release of cytochrome c, which triggers the caspase cascade [<a href="#rid26">26</a>].</p><p>The proapoptotic factors contained in the mitochondria include cytochrome c, apoptosis-inducing factor, and second mitochondria-derived activator of caspases. Bcl-2 family members act as a checkpoint during apoptosis. Bax and Bak are the Bcl-2 protein family members that form the pore in the outer mitochondrial membrane through which the pro-apoptotic factors can be released.</p><p class="headingAnchor" id="H1643464123"><span class="h2">Calcium homeostasis</span><span class="headingEndMark"> — </span>Mitochondria are involved in maintaining calcium homeostasis [<a href="#rid26">26</a>]. Increases in calcium can lead to release of proapoptotic factors from mitochondria and can trigger the opening of the mitochondrial permeability transition pore, which can lead to cell death. (See <a class="local">'Apoptosis'</a> above.)</p><p class="headingAnchor" id="H241755318"><span class="h2">Inflammation and immunity</span><span class="headingEndMark"> — </span>Mitochondria have been shown to participate both in the innate immune response [<a href="#rid27">27,29</a>]. Similar pathways appear to be activated in autoimmune diseases [<a href="#rid28">28</a>]. </p><p>More than a dozen distinct but potentially interconnected pathways can result in:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immune</strong> <strong>activation </strong>– By production of interleukins and tumor necrosis factor (TNF).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chemotaxis and activation of immune cells</strong> – Including antigen presenting cells, neutrophils, dendritic and gamma-delta cells.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Activation of apoptosis</strong> – The NLRP3-inflammasome (multimeric complex that can activate caspase 1 and promote cytokine production), and mitophagy pathways.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>DAMPs</strong> – Release or degradation of mitochondrial danger-associated molecular patterns (DAMPs) activates signaling pathways in response to cellular damage. Mitochondrial DAMPs include mtDNA, mitochondrial ATP, N-formyl peptides, and mitochondrial transcription factor A. (See  <a class="medical medical_review" href="/d/html/13572.html" rel="external">"An overview of the innate immune system", section on 'Damage-associated molecular patterns'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen presentation</strong> – Occurs on major histocompatibility complex (MHC) class I molecules in macrophages and dendritic cells [<a href="#rid30">30</a>].</p><p></p><p>The following are examples of how these pathways can be involved in specific infectious or inflammatory processes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral infections</strong> – Mitochondrial antiviral signaling (MAVS) protein is located on the outer mitochondrial membrane and is required for signaling through retinoic acid-inducible gene I (RIG-I)-like receptors (RLR), which are part of the cell's innate immune response to viral infection. Reactive oxygen species (ROS) produced by mitochondria can induce RLR signaling in response to viral infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial infections</strong> – In the cellular response to bacterial pathogens, toll-like receptor 1 activation promotes translocation of tumor necrosis factor receptor-associated factor 6 (TRAF6) to the mitochondria and binding to evolutionary conserved signaling intermediate in Toll pathways (ECSIT) on the outer mitochondrial membrane, in turn leading to mitochondrial ROS production. ROS can directly kill bacteria or activate the NF-kappa B and mitogen-activated protein kinase (MAPK) signaling pathways, which cumulate in pro-inflammatory cytokine production. Interferon gamma signaling can increase mitochondrial ROS production.</p><p></p><p class="headingAnchor" id="H3294157051"><span class="h2">Role in aging</span><span class="headingEndMark"> — </span>Mitochondrial dysfunction is considered to be a hallmark of aging, and age-related changes in mitochondrial function may contribute to frailty [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/14605.html" rel="external">"Normal aging", section on 'Molecular basis of aging'</a> and  <a class="medical medical_review" href="/d/html/3010.html" rel="external">"Frailty", section on 'Other stress response and metabolic systems'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">MITOCHONDRIAL GENETICS</span><span class="headingEndMark"> — </span>Mitochondria are under the dual control of nuclear DNA and mitochondrial DNA (mtDNA) [<a href="#rid32">32,33</a>]. </p><p class="headingAnchor" id="H223263738"><span class="h2">Nuclear genes</span><span class="headingEndMark"> — </span>Each mitochondrion has approximately 1700 proteins, including more than 200 respiratory chain proteins [<a href="#rid34">34</a>]. All but 13 of these are encoded by nuclear DNA and synthesized in the cytosol, then imported to the mitochondrion. mtDNA only encodes 13 proteins involved in the respiratory chain and some regulatory RNAs. (See <a class="local">'Mitochondrial DNA, RNA, and protein synthesis'</a> above.)</p><p>Pathogenic variants in nuclear genes that affect mitochondrial function follow Mendelian inheritance patterns (autosomal dominant, autosomal recessive, or X-linked). (See  <a class="medical medical_review" href="/d/html/2897.html" rel="external">"Inheritance patterns of monogenic disorders (Mendelian and non-Mendelian)", section on 'Mendelian inheritance patterns'</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Mitochondrial genes</span><span class="headingEndMark"> — </span>The circular double stranded mitochondrial DNA (mtDNA) contains 11 protein-coding genes that are transcribed into 13 proteins  (<a class="graphic graphic_figure graphicRef73757" href="/d/graphic/73757.html" rel="external">figure 2</a>). In addition, mtDNA encodes for 22 transfer RNAs and 2 ribosomal RNAs, giving a total of 37 mitochondrial genes. (See <a class="local">'Mitochondrial DNA, RNA, and protein synthesis'</a> above.)</p><p class="headingAnchor" id="H3156020109"><span class="h3">Maternal inheritance</span><span class="headingEndMark"> — </span>One of the most distinctive features of mtDNA is maternal inheritance. During oocyte fertilization, the sperm brings only a small quantity of mitochondria, approximately 100 times less than the oocyte [<a href="#rid35">35</a>]. With subsequent cell divisions, paternal mitochondria are diluted and/or targeted and destroyed, possibly through ubiquitination [<a href="#rid36">36</a>]. As a result, all the mitochondria in the offspring come almost exclusively from the maternal line. Evidence from animals suggests that paternal mitochondria transmission does occur [<a href="#rid37">37</a>]; however, there has been only one reported human case of paternal transmission in muscle cells [<a href="#rid38">38</a>].</p><p>Additional details of maternal inheritance are presented separately. (See  <a class="medical medical_review" href="/d/html/2897.html" rel="external">"Inheritance patterns of monogenic disorders (Mendelian and non-Mendelian)", section on 'Mitochondrial inheritance'</a>.)</p><p>Females with primary mitochondrial disorders due to variants in mitochondrial genes who wish to have offspring lacking the disorder can undergo in vitro fertilization with techniques using donor egg mitochondria and maternal nuclear DNA. (See  <a class="medical medical_review" href="/d/html/7404.html" rel="external">"In vitro fertilization: Overview of clinical issues and questions", section on 'Other uses'</a>.)</p><p class="headingAnchor" id="H2556656091"><span class="h3">High mutation rate and variable phenotypic expression</span><span class="headingEndMark"> — </span>mtDNA has a higher mutation rate than nuclear DNA. This is due to the lack of histones, which have a protective function, and the abundance of oxygen radicals that can cause DNA damage. (See <a class="local">'Metabolism and ATP production'</a> above.) </p><p>Many point mutations, as well as insertions, deletions, duplications, and rearrangements of varying size and complexity have been reported [<a href="#rid39">39,40</a>]. (See <a class="local">'Primary mitochondrial disorders'</a> above.)</p><p>While the nuclear genome is diploid, containing only two homologous copies of each chromosome (one paternal and one maternal), the mitochondrial genome is polyploid, containing 1 to 10 molecules of mitochondrial DNA within its matrix. This variable copy number, combined with the variable number of mitochondria in each cell (see <a class="local">'Distribution'</a> above), has important implications for the phenotypic expression of a mutation. (See <a class="local">'Heteroplasmy'</a> below.)</p><p>A shift in mitochondrial mutation load may be seen in the offspring of mothers affected by pathogenic variants in mtDNA. This shift is a result of the restriction-amplification event that occurs during oocyte maturation and it is termed the mitochondrial bottleneck effect. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Restriction</strong> – During the meiotic cell division that produces primary oocytes, a small proportion of the total mitochondria in the primordial germ cell is randomly segregated into each primary oocyte (ie, restriction) [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/d/html/129424.html" rel="external">"Basic genetics concepts: Chromosomes and cell division", section on 'Meiosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amplification</strong> – With maturation, there is rapid replication (ie, amplification) of the mitochondrial DNA in each primary oocyte. </p><p></p><p>Thus, the mature oocyte may contain a different proportion of a variant in mtDNA compared with the proportion found in the primordial germ cell.</p><p>Sporadic mutations of mtDNA can also occur in the germ cells, leading to a different mtDNA composition than that in maternal cells.</p><p class="headingAnchor" id="H8"><span class="h3">Heteroplasmy</span><span class="headingEndMark"> — </span>Each mitochondrion has several DNA molecules, and each cell has several hundred to 1000 mitochondria. In a normal state, all these mtDNAs are identical (homoplasmy). When a pathogenic mutation occurs, it is generally present in some but not all of these mtDNA copies (heteroplasmy).</p><p>Heteroplasmy can apply to a single mitochondrion (some pathologic variants mixed with wildtype versions of the gene within one mitochondrion), to the cell (unaffected mitochondria mixed with mitochondria carrying the pathogenic variant), or to specific tissues (some affected cells mixed with some unaffected cells).</p><p>It was once believed that all pathogenic variants are heteroplasmic. This view is no longer accepted, as homoplasmic pathogenic variants have been found to cause disease [<a href="#rid42">42</a>]. Similarly, benign variants are usually but not always homoplasmic. (See  <a class="medical medical_review" href="/d/html/96539.html" rel="external">"Secondary findings from genetic testing", section on 'Definitions and classification of variants'</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Threshold effect</span><span class="headingEndMark"> — </span>Given variable mitochondrial heteroplasmy, not all cells in a tissue will be affected by a pathogenic variant in a mitochondrial gene. As a consequence, a minimal number of affected mtDNA molecules must be present before respiratory chain failure and cellular dysfunction occur. Clinical signs do not become apparent until enough cells are affected. This is known as the threshold effect.</p><p>The threshold varies between different body tissues. It is lower in tissues mainly relying on oxidative phosphorylation for energy production, such as the brain, the retina, the skeletal muscles, and the heart. This explains why systemic mitochondrial defects often manifest clinically in these organs. Furthermore, the amount of heteroplasmy (or "mutation load") in a specific tissue often correlates with severity of the illness in that tissue [<a href="#rid43">43</a>]. In most mitochondrial disorders with overt disease, the mutation load is quite high, generally ≥80 percent [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H1099527164"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/120961.html" rel="external">"Society guideline links: Mitochondrial disorders"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary mitochondrial diseases</strong> – Primary mitochondrial diseases are genetically determined disorders in which mitochondrial dysfunction is responsible for the disorder. They include myopathies, encephalomyopathies, and multisystemic diseases  (<a class="graphic graphic_table graphicRef55067" href="/d/graphic/55067.html" rel="external">table 1</a>). They can be caused by pathogenic variants in germline nuclear DNA or mitochondrial DNA (mtDNA). The overall prevalence is approximately 1 in 4300. (See <a class="local">'Primary mitochondrial disorders'</a> above and <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other causes of mitochondrial dysfunction</strong> – A range of human conditions exhibit mitochondrial dysfunction, including neurodegenerative, cardiovascular, cancer, immune, hepatic, and autoimmune disorders. Certain medications (antiviral reverse transcriptase inhibitors, antibiotics) can cause mitochondrial dysfunction. (See <a class="local">'Disorders with altered mitochondrial function'</a> above and <a class="local">'Drug-induced mitochondrial disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Structure and regulation</strong> – Mitochondria are derived from aerobic bacteria that invaded the proto eukaryotic cell over a billion years ago. They are present in all eukaryotic cells except mature red blood cells and are especially abundant in cells with high energy demands (hundreds to thousands per cell). They have four main compartments  (<a class="graphic graphic_figure graphicRef67253" href="/d/graphic/67253.html" rel="external">figure 1</a>) and form a dynamic interconnected network undergoing fusion and fission. Their circular double-stranded genome encodes 13 proteins of the respiratory cascade  (<a class="graphic graphic_figure graphicRef73757" href="/d/graphic/73757.html" rel="external">figure 2</a>), plus genes for transfer and ribosomal RNAs. mtDNA replication is independent of the cell division cycle. (See <a class="local">'Structure and regulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Functions</strong> – Mitochondria are the powerhouses of the cell, producing energy in the form of ATP (adenosine triphosphate) via the Krebs cycle, fatty acid oxidation, and oxidative phosphorylation  (<a class="graphic graphic_figure graphicRef82715" href="/d/graphic/82715.html" rel="external">figure 4</a>). They also have roles in apoptosis, calcium homeostasis, inflammation and immunity, and aging. (See <a class="local">'Cellular functions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nuclear genes</strong> – Primary mitochondrial diseases due to pathogenic variants in nuclear genes follow Mendelian inheritance patterns (autosomal dominant, autosomal recessive, or X-linked). (See <a class="local">'Nuclear genes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mitochondrial genes</strong> – Mitochondrial genes exhibit maternal inheritance since only the oocyte provides mitochondria for the developing embryo. mtDNA has a higher mutation rate than nuclear DNA due to lack of protective histones and presence of abundant DNA-damaging oxygen radicals. When a pathogenic mutation occurs, it is generally present in a subset of mtDNA copies (heteroplasmy), which can apply to the mitochondrion, cell, or tissue. This in turn produces a threshold effect, in which clinical signs do not become apparent until a threshold number of cells are affected. (See <a class="local">'Mitochondrial genes'</a> above.)</p><p></p><p class="headingAnchor" id="H3918107484"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Rami Massie and Angela Genge, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015; 77:753.</a></li><li class="breakAll">Chinnery PF. Mitochondrial disorders overview. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1224/ (Accessed on February 21, 2017).</li><li><a class="nounderline abstract_t">DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 2005; 15:276.</a></li><li><a class="nounderline abstract_t">DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006; 18:636.</a></li><li><a class="nounderline abstract_t">Lightowlers RN, Taylor RW, Turnbull DM. Mutations causing mitochondrial disease: What is new and what challenges remain? Science 2015; 349:1494.</a></li><li><a class="nounderline abstract_t">DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013; 9:429.</a></li><li><a class="nounderline abstract_t">Nardin RA, Johns DR. Mitochondrial dysfunction and neuromuscular disease. Muscle Nerve 2001; 24:170.</a></li><li><a class="nounderline abstract_t">Friedman JR, Nunnari J. Mitochondrial form and function. Nature 2014; 505:335.</a></li><li><a class="nounderline abstract_t">Roger AJ, Muñoz-Gómez SA, Kamikawa R. The Origin and Diversification of Mitochondria. Curr Biol 2017; 27:R1177.</a></li><li><a class="nounderline abstract_t">Wallace DC. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005; 354:169.</a></li><li><a class="nounderline abstract_t">Zhang ZW, Cheng J, Xu F, et al. Red blood cell extrudes nucleus and mitochondria against oxidative stress. IUBMB Life 2011; 63:560.</a></li><li><a class="nounderline abstract_t">Hirata S, Hoshi K, Shoda T, Mabuchi T. Spermatozoon and mitochondrial DNA. Reprod Med Biol 2002; 1:41.</a></li><li><a class="nounderline abstract_t">Lu YW, Claypool SM. Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes. Front Genet 2015; 6:3.</a></li><li><a class="nounderline abstract_t">Garbincius JF, Elrod JW. Mitochondrial calcium exchange in physiology and disease. Physiol Rev 2022; 102:893.</a></li><li><a class="nounderline abstract_t">Giorgi C, Missiroli S, Patergnani S, et al. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Signal 2015; 22:995.</a></li><li><a class="nounderline abstract_t">Filadi R, Theurey P, Pizzo P. The endoplasmic reticulum-mitochondria coupling in health and disease: Molecules, functions and significance. Cell Calcium 2017; 62:1.</a></li><li><a class="nounderline abstract_t">Gao J, Wang L, Liu J, et al. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases. Antioxidants (Basel) 2017; 6.</a></li><li><a class="nounderline abstract_t">Saravanan S, Lewis CJ, Dixit B, et al. The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics. Biomedicines 2022; 10.</a></li><li class="breakAll">https://mitomap.org/pub/MITOMAP/MitomapFigures/mitomapgenome.pdf (Accessed on December 04, 2023).</li><li><a class="nounderline abstract_t">Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290:457.</a></li><li><a class="nounderline abstract_t">Gilkerson R, Bravo L, Garcia I, et al. The mitochondrial nucleoid: integrating mitochondrial DNA into cellular homeostasis. Cold Spring Harb Perspect Biol 2013; 5:a011080.</a></li><li><a class="nounderline abstract_t">De Silva D, Tu YT, Amunts A, et al. Mitochondrial ribosome assembly in health and disease. Cell Cycle 2015; 14:2226.</a></li><li><a class="nounderline abstract_t">Powell CA, Nicholls TJ, Minczuk M. Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease. Front Genet 2015; 6:79.</a></li><li><a class="nounderline abstract_t">Pandey A, Pain J, Ghosh AK, et al. Fe-S cluster biogenesis in isolated mammalian mitochondria: coordinated use of persulfide sulfur and iron and requirements for GTP, NADH, and ATP. J Biol Chem 2015; 290:640.</a></li><li><a class="nounderline abstract_t">Herrmann JM, Longen S, Weckbecker D, Depuydt M. Biogenesis of mitochondrial proteins. Adv Exp Med Biol 2012; 748:41.</a></li><li><a class="nounderline abstract_t">Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun 2017; 482:426.</a></li><li><a class="nounderline abstract_t">West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011; 11:389.</a></li><li><a class="nounderline abstract_t">Marchi S, Guilbaud E, Tait SWG, et al. Mitochondrial control of inflammation. Nat Rev Immunol 2023; 23:159.</a></li><li><a class="nounderline abstract_t">Mills EL, Kelly B, O'Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol 2017; 18:488.</a></li><li><a class="nounderline abstract_t">Matheoud D, Sugiura A, Bellemare-Pelletier A, et al. Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell 2016; 166:314.</a></li><li><a class="nounderline abstract_t">López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: An expanding universe. Cell 2023; 186:243.</a></li><li><a class="nounderline abstract_t">Saneto RP. Genetics of Mitochondrial Disease. Adv Genet 2017; 98:63.</a></li><li><a class="nounderline abstract_t">Wallace DC. Mitochondrial genetic medicine. Nat Genet 2018; 50:1642.</a></li><li><a class="nounderline abstract_t">Area-Gomez E, Schon EA. Mitochondrial genetics and disease. J Child Neurol 2014; 29:1208.</a></li><li><a class="nounderline abstract_t">Schwartz M, Vissing J. New patterns of inheritance in mitochondrial disease. Biochem Biophys Res Commun 2003; 310:247.</a></li><li><a class="nounderline abstract_t">Sutovsky P, Moreno RD, Ramalho-Santos J, et al. Ubiquitin tag for sperm mitochondria. Nature 1999; 402:371.</a></li><li><a class="nounderline abstract_t">Kvist L, Martens J, Nazarenko AA, Orell M. Paternal leakage of mitochondrial DNA in the great tit (Parus major). Mol Biol Evol 2003; 20:243.</a></li><li><a class="nounderline abstract_t">Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. N Engl J Med 2002; 347:576.</a></li><li class="breakAll">MITOMAP: A human mitochondrial genome database. http://mitomap.org/MITOMAP (Accessed on February 21, 2017).</li><li><a class="nounderline abstract_t">Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med 2012; 366:1132.</a></li><li><a class="nounderline abstract_t">Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005; 6:389.</a></li><li><a class="nounderline abstract_t">McFarland R, Clark KM, Morris AA, et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002; 30:145.</a></li><li><a class="nounderline abstract_t">Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998; 121 ( Pt 10):1889.</a></li></ol></div><div id="topicVersionRevision">Topic 5148 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25652200" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25652200" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15792866" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mitochondrial encephalomyopathies: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17053512" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mitochondrial myopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26404827" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mutations causing mitochondrial disease: What is new and what challenges remain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23835535" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The clinical maze of mitochondrial neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11180201" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mitochondrial dysfunction and neuromuscular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24429632" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Mitochondrial form and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29112874" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Origin and Diversification of Mitochondria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16024186" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21698761" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Red blood cell extrudes nucleus and mitochondria against oxidative stress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29699072" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Spermatozoon and mitochondrial DNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25691889" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34698550" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Mitochondrial calcium exchange in physiology and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25557408" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28108029" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The endoplasmic reticulum-mitochondria coupling in health and disease: Molecules, functions and significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28379197" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35203698" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35203698" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7219534" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Sequence and organization of the human mitochondrial genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23637282" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The mitochondrial nucleoid: integrating mitochondrial DNA into cellular homeostasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26030272" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mitochondrial ribosome assembly in health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25806043" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25398879" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fe-S cluster biogenesis in isolated mammalian mitochondria: coordinated use of persulfide sulfur and iron and requirements for GTP, NADH, and ATP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22729854" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Biogenesis of mitochondrial proteins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28212726" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The role of mitochondria in metabolism and cell death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21597473" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Mitochondria in innate immune responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35879417" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mitochondrial control of inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28418387" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mitochondria are the powerhouses of immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27345367" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36599349" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hallmarks of aging: An expanding universe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28942795" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Genetics of Mitochondrial Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30374071" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mitochondrial genetic medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25028417" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Mitochondrial genetics and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14521902" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : New patterns of inheritance in mitochondrial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586873" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ubiquitin tag for sperm mitochondria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598691" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Paternal leakage of mitochondrial DNA in the great tit (Parus major).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12192017" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Paternal inheritance of mitochondrial DNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12192017" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Paternal inheritance of mitochondrial DNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22435372" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Monogenic mitochondrial disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15861210" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mitochondrial DNA mutations in human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11799391" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9798744" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
